Please click on an icon to download a file. You can view and download presentations from other days of the conference by clicking on the links below:
Click here to view presentations from the BHIVA Young Consultants Forum (Tuesday 17th April 2012).
BHIVA Plenary Session 2 - Antiretroviral treatment and health
Discordant responders: what have we learnt?
Professor Mario Clerici, University of Milan, Italy
People with viral supression on ART: what are the remaining serious disease risks due to HIV?
Professor Andrew Phillips, University College London Medical School
Oral Research Presentations: Session 2 - Complications of HIV disease or treatment
Abstract O7: Comprehensive cardiac magnetic resonance reveals HIV is associated with high burden of myocardial disease
Dr Cameron Holloway, University of Oxford
Abstract O8: Coronary heart disease is associated with renal impairment in HIV positive patients
Dr Mitesh Desai, Guy's and St Thomas' NHS Foundation Trust, London
Abstract O9: Polymorphisms at genes involved in the purine metabolic pathway influence the risk of non-cirrhotic portal hypertension in HIV-infected patients
Dr Muge Cevik, Chelsea and Westminster Hospital, London
Abstract O10: Depression and virological status among UK HIV outpatients: results from a multicentre study
Dr Fiona Lampe, University College London
Abstract O11: Microglial cell activation is visualised with [11C]-PK11195 positron emission tomography (PET) in neuro-asymptomatic HIV infected subjects on effective antiretroviral therapy
Dr Lucy Garvey, Imperial College Healthcare NHS Trust, London
Abstract O12: Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting
Mr Timothy Rawson, Imperial Colege London
Abstract O13: HIV status does not impact on outcome in patients with Hodgkin lymphoma treated with ABVD chemotherapy in the HAART era
Dr Silvia Montoto, Barts and The London NHS Trust
Abstract O14: Immunological manifestations of increasing age, ART duration and time since diagnosis within the ageing HIV-1+ cohort
Dr Samantha Westrop, Imperial College London
Abstract O15: The antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ cell decline in HIV-1 infection
Dr Lucy Dorrell, University of Oxford
BHIVA Lunchtime Workshop 3 - Clinico-pathological SpR case presentations
Non-Hodgkins lymphoma responding to antiretroviral therapy alone
Dr Emily Cheserem, King's College Hospital, London
You give me fever...
Dr Emily Mabonga, Brighton and Sussex University Hospitals NHS Trust
Is it always straightforward?
Dr Huda Taha, Coventry and Warwickshire Hospital
BHIVA Lunchtime Workshop 4
What can your Comprehensive Local Research Network (CLRN) do for you?
Professor Robert Read, The University of Sheffield Medical School and Chair, National Specialty Group for Infectious Diseases and Microbiology
Oral Research Presentations: Session 3 - Prevention and testing
Abstract O16: HIV indicator diseases across Europe study (HIDES I): results from the pilot phase
Dr Michael Rayment, Chelsea and Westminster NHS Foundation Trust, London
Abstract O17: General Medical Council guidance in relation to testing for HIV in patients lacking mental capacity: a national survey of opinion from Intensive Care
Dr Mark Dodd, Sheffield Teaching Hospitals
Abstract O18: Opt-out HIV testing policy implemented as routine standard of care for acute medical admissions in a high prevalance area: effective and sustainable
Dr Alison Barbour, Croydon University Hospital
Abstract O19: Recently acquired HIV infections: an overview of surveillance in the UK
Miss Adamma Aghaizu, Health Protection Agency, London
Abstract O20: Can point of care HIV testing in primary care increase identification of HIV? The RHIVA2 cluster randomised controlled trial – update
Dr Werner Leber, Queen Mary University of London
Abstract O21: 4th generation (Ag/Ab) HIV testing: 47% of clinics contradict current guidelines
Miss Emma Rezel, London School of Hygiene and Tropical Medicine
Abstract O22: HIV partner home sampling by oral fluid: feasibility, acceptability and outcomes
Dr Gill Bell, Sheffield Teaching Hospitals NHS Foundation Trust
Abstract O23: Who would use PrEP ? Predictions of use among MSM in London
Miss Adamma Aghaizu, Health Protection Agency
Abstract O24: HIV-1 transmitted drug resistance (TDR), in paired plasma and seminal fluid: persistance in semen and little evidence of differential evolution
Dr Simon Shaw, Royal Sussex County Hospital, Brighton
BHIVA Audit Session
Audit of key HIV outcomes including psychological and adherence support
Dr Mitesh Desai, Guy's and St Thomas' NHS Foundation Trust, London
BHIVA Plenary Session 3 - The virtual clinic
Memory loss
Dr Ria Daly, Birmingham Heartlands Hospital
Multi-drug resistant mycobacteria
Dr Sharanjit Dhoot, Chelsea and Westminster Hospital, London
Cancer
Dr Sophia Davies, Birmingham Heartlands Hospital
Expert Panel
Dr Alan Winston, Imperial College London and Professor Mark Bower, Chelsea and Westminster Hospital, London and Dr Ed Wilkins, North Manchester General Hospital and Professor Georg Behrens, Hannover Medical School, Germany